Breaking tolerance to self, circulating natural killer cells expressing inhibitory KIR for non-self HLA exhibit effector function after T cell-depleted allogeneic hematopoietic cell transplantation

Blood

Volumn 113, Issue 16, 2009, Pages 3875-3884

  Yu, Junli ^a   Venstrom, Jeffrey M ^a   Liu, Xiao Rong ^a   Pring, James ^a   Hasan, Reenat S ^a   O'Reilly, Richard J ^a   Hsu, Katharine C ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BUSULFAN; CYCLOPHOSPHAMIDE; FAS ANTIGEN; FLUDARABINE; GAMMA INTERFERON; HLA ANTIGEN; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR; MELPHALAN; NATURAL KILLER CELL RECEPTOR NKG2A; THIOTEPA; KLRC1 PROTEIN, HUMAN; KLRD1 PROTEIN, HUMAN; NATURAL KILLER CELL LECTIN LIKE RECEPTOR SUBFAMILY C; NATURAL KILLER CELL LECTIN LIKE RECEPTOR SUBFAMILY D;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOCYTIC LEUKEMIA; ADOLESCENT; ADULT; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ALLOGRAFT; ALLOIMMUNITY; ARTICLE; CELL MATURATION; CHILD; CHRONIC MYELOID LEUKEMIA; CLINICAL ARTICLE; CYTOKINE PRODUCTION; DONOR; EFFECTOR CELL; FEMALE; GRAFT RECIPIENT; GRAFT REJECTION; HUMAN; LYMPHOCYTE FUNCTION; MALE; MOLECULAR MECHANICS; MYELOABLATIVE CONDITIONING; MYELODYSPLASTIC SYNDROME; NATURAL KILLER CELL; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCHOOL CHILD; T CELL DEPLETION; TRANSPLANTATION TOLERANCE; WHOLE BODY RADIATION; ALLOTRANSPLANTATION; CELLULAR IMMUNITY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; IMMUNOLOGICAL TOLERANCE; IMMUNOLOGY; LEUKEMIA; LYMPHOCYTE DEPLETION; MIDDLE AGED; RETROSPECTIVE STUDY;

ADULT; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HLA ANTIGENS; HUMANS; IMMUNITY, CELLULAR; INTERFERON-GAMMA; KILLER CELLS, NATURAL; LEUKEMIA; LYMPHOCYTE DEPLETION; MALE; MIDDLE AGED; MYELODYSPLASTIC SYNDROMES; NK CELL LECTIN-LIKE RECEPTOR SUBFAMILY C; NK CELL LECTIN-LIKE RECEPTOR SUBFAMILY D; RECEPTORS, KIR; RETROSPECTIVE STUDIES; SELF TOLERANCE; TRANSPLANTATION, HOMOLOGOUS;

EID: 65549133016     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2008-09-177055     Document Type: Article

References (49)

1. Biron CA, Nguyen KB, Pien GC, Cousens LP, Salazar-Mather TP. Natural killer cells in antiviral defense: function and regulation by innate cytokines. Annu Rev Immunol. 1999;17:189-220.
2. Trinchieri G. Biology of natural killer cells. Adv Immunol. 1989;47:187-376.
3. Ljunggren HG, Karre K. In search of the missing self: MHC molecules and NK cell recognition. Immunol Today. 1990;11:237-244.
4. Colonna M, Samaridis J. Cloning of immuno-globulin- superfamily members associated with HLA-C and HLA-B recognition by human natural killer cells. Science. 1995;268:405-408.
5. Long EO. Regulation of immune responses through inhibitory receptors. Annu Rev Immunol. 1999;17:875-904. (Pubitemid 29241142)
6. Lanier L. NK cell recognition. Annu Rev Immunol. 2005;23:225-274.
7. + HLA-B and HLA-A alleles with KIR3DL1: implications for patient and donor suitability for hap-loidentical stem cell transplantations. Blood. 2008;112:435-443.
8. Stern M, Ruggeri L, Capanni M, Mancusi A, Velardi A. Human leukocyte antigens A23, A24 and A32 but not A25 are ligands for KIR3DL1. Blood. 2008;112:708-710.
9. Anfossi N, Andre P, Guia S, et al. Human NK cell education by inhibitory receptors for MHC class I. Immunity. 2006;25:331-342. (Pubitemid 44224147)
10. Yu J, Heller G, Chewning J, Kim S, Yokoyama W, Hsu K. Hierarchy of the human natural killer cell response is determined by class and quantity of inhibitory receptors for self-HLA-B and HLA-C ligands. J Immunol. 2007;179:5977-5989.
11. Yawata M, Yawata N, Draghi M, Partheniou F, Little A, Parham P. MHC class I-specific inhibitory receptors and their ligands structure diverse human NK cell repertoires towards a balance of missing-self response. Blood. 2008;112:2369-2380.
12. Asai O, Longo DL, Tian Z, et al. Suppression of graft-versus-host disease and amplification of graft-versus-tumor effects by activated natural killer cells after allogeneic bone marrow transplantation. J Clin Invest. 1998;101:1835-1842. (Pubitemid 28226101)
13. Ruggeri L, Capanni M, Urbani E, et al. Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants. Science. 2002;295:2097-2100. (Pubitemid 34229476)
14. Bornhauser M, Thiede C, Brendel C, et al. Stable engraftment after megadose blood stem cell transplantation across the HLA barrier: the case for natural killer cells as graft-facilitating cells. Transplantation. 1999;68:87-88. (Pubitemid 29352836)
15. Hauch M, Gazzola MV, Small T, et al. Anti-leukemia potential of interleukin-2 activated natural killer cells after bone marrow transplantation for chronic myelogenous leukemia. Blood. 1990;75: 2250-2262. (Pubitemid 20181179)
16. Ruggeri L, Capanni M, Casucci M, et al. Role of natural killer cell alloreactivity in HLA-mismatched hematopoietic stem cell transplantation. Blood. 1999;94:333-339. (Pubitemid 29300166)
17. Zeis M, Uharek L, Glass B, et al. Allogeneic NK cells as potent anti-leukemic effector cells after allogeneic bone marrow transplantation in mice. Transplantation. 1995;59:1734-1736.
18. Beelen D, Ottinger H, Ferencik S, et al. Genotypic inhibitory killer immunoglobulin-like receptor ligand incompatibility enhances the long-term antileukemic effect of unmodified allogeneic hematopoietic stem cell transplantation in patients with myeloid leukemias. Blood. 2005;105:2594-2600. (Pubitemid 40387064)
19. Clausen J, Wolf D, Petzer A, et al. Impact of natural killer cell dose and donor killer-cell immunoglobulin- like receptor (KIR) genotype on outcome following human leucocyte antigen-identical haematopoietic stem cell transplantation. Clin Exp Immunol. 2007;148:520-528. (Pubitemid 46701023)
20. Hsu K, Gooley T, Malkki M, et al. KIR ligands and prediction of relapse after unrelated donor hematopoietic cell transplantation for hematologic malignancy. Biol Blood Marrow Transplant. 2006;12: 828-836. (Pubitemid 44070671)
21. Hsu K, Keever-Taylor C, Wilton A, et al. Improved outcome in allogeneic hematopoietic stem cell transplantation in acute myelogenous leukemia (AML) predicted by donor KIR genotype and recipient HLA genotype in T-cell-depleted HLA-identical sibling transplants. Blood. 2005;105: 4878-4884.
22. Miller J, Cooley S, Parham P, et al. Missing KIR-ligands is associated with less relapse and increased graft versus host disease (GVHD) following unrelated donor allogeneic HCT. Blood. 2007; 109:5058-5061. (Pubitemid 46827806)
23. Hsu KC, Liu X, Selvakumar A, Mickelson E, O'Reilly RJ, Dupont B. Killer Ig-like receptor haplotype analysis by gene content: evidence for genomic diversity with a minimum of six basic framework haplotypes, each with multiple sub-sets. J Immunol. 2002;169:5123-5134.
24. Bryceson YT, March ME, Barber DF, Ljunggren HG, Long EO. Cytolytic granule polarization and degranulation controlled by different receptors in resting NK cells. J Exp Med. 2005;202:1001-1012.
25. Rubio V, Stuge T, Singh N, et al. Ex vivo identification, isolation and analysis of tumor-cytolytic T cells. Nat Med. 2003;9:1377-1382. (Pubitemid 37466186)
26. Wolint P, Betts M, Koup R, Oxenius A. Immediate cytotoxicity but not degranulation distinguishes effector and memory subsets of CD8+ T cells. J Exp Med. 2004;199:925-936. (Pubitemid 38481084)
27. Nguyen S, Dhedin N, Vernant J, et al. NK-cell reconstitution after haploidentical hematopoietic stem-cell transplantations: immaturity of NK cells and inhibitory effect of NKG2A override GvL effect. Blood. 2005;105:4135-4142. (Pubitemid 40656166)
28. Shilling H, McQueen KL, Cheng N, Shizuru J, Negrin R, Parham P. Reconstitution of NK cell receptor repertoire following HLA-matched hematopoietic cell transplantation. Blood. 2003;101: 3730-3740. (Pubitemid 36857966)
29. Cooley S, Xiao F, Pitt M, et al. A subpopulation of human peripheral blood NK cells that lacks inhibitory receptors for self-MHC is developmentally immature. Blood. 2007;110:578-586.
30. Dulphy N, Haas P, Busson M, et al. An unusual CD56(bright) CD16(low) NK cell subset dominates the early posttransplant period following HLA-matched hematopoietic stem cell transplantation. J Immunol. 2008;181:2227-2237.
31. Gays F, Martin K, Kenefeck R, Aust JG, Brooks CG. Multiple cytokines regulate the NK gene complex-encoded receptor repertoire of mature NK cells and T cells. J Immunol. 2005;175:2938-2947. (Pubitemid 41170511)
32. Min CK, Lee WY, Min DJ, et al. The kinetics of circulating cytokines including IL-6, TNF-α, IL-8 and IL-10 following allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant. 2001;28:935-940.
33. Schots R, Kaufman L, Riet IV, et al. Proinflammatory cytokines and their role in the development of major transplant-related complications in the early phase after allogeneic bone marrow transplantation. Leukemia. 2003;17:1150-1156. (Pubitemid 36722247)
34. Vivier E, Anfossi N. Inhibitory NK-cell receptors on T cells: witness of the past, actors of the future. Nat Rev Immunol. 2004;4:190-198. (Pubitemid 38339085)
35. Kim S, Poursine-Laurent J, Truscott S, et al. Licensing of natural killer cells by host major histocompatibility complex class I molecules. Nature. 2005;436:709-713. (Pubitemid 41117274)
36. Fernandez N, Treiner E, Vance R, Jamieson A, Lemieux S, Raulet D. A subset of natural killer cells achieves self-tolerance without expressing inhibitory receptors specific for self-MHC molecules. Blood. 2005;105:4416-4423. (Pubitemid 40720789)
37. Sun J, Lanier L. Cutting edge: viral infection breaks NK cell tolerance to "missing self." J Immunol. 2008;181:7453-7457.
38. Giebel S, Locatelli F, Lamparelli T, et al. Survival advantage with KIR ligand incompatibility in hematopoietic stem cell transplantation from unrelated donors. Blood. 2003;102:814-819. (Pubitemid 36917769)
39. Cooley S, McCullar V, Wangen R, et al. KIR reconstitution is altered by T cells in the graft and correlates with clinical outcomes after unrelated donor transplantation. Blood. 2005;106:4370-4376. (Pubitemid 41775950)
40. Freud A, Caligiuri M. Human natural killer cell development. Immunol Rev. 2006;214:46-72.
41. Miller J, McCullar V. Human natural killer cells with polyclonal lectin and immunoglobulinlike receptors develop from single hematopoietic stem cells with preferential expression of NKG2A and KIR2DL2/L3/S2. Blood. 2001;98:705-713.
42. Takei F, McQueen K, Maeda M, et al. Ly49 and CD94/NKG2: developmentally regulated expression and evolution. Immunol Rev. 2001;181:90-103. (Pubitemid 32703398)
43. Vago L, Forno B, Sormani M, et al. Temporal, quantitative, and functional characteristics of single-KIR-positive alloreactive natural killer cell recovery account for impaired graft-versus-leukemia activity after haploidentical hematopoietic stem cell transplantation. Blood. 2008; 112:3488-3499.
44. Moretta A, Bottino C, Vitale M, et al. Activating receptors and coreceptors involved in human natural killer cell-mediated cytolysis. Ann Rev Immunol. 2001;19:197-223. (Pubitemid 32368034)
45. Sivori S, Vitale M, Morelli L, et al. p46, a novel natural killer cell-specific surface molecule that mediates cell activation. J Exp Med. 1997;186: 1129-1136. (Pubitemid 27441156)
46. Pende D, Parolini S, Pessino A, et al. Identification and molecular characterization of NKp30, a novel triggering receptor involved in natural cytotoxicity mediated by human natural killer cells. J Exp Med. 1999;190:1505-1516.
47. Fischer J, Ottinger H, Ferencik S, et al. Relevance of C1 and C2 epitopes for hemopoietic stem cell transplantation: role for sequential acquisition of HLA-C-specific inhibitory killer Ig-like receptor. J Immunol. 2007;178:3918-3923. (Pubitemid 46417662)
48. Ruggeri L, Mancusi A, Capanni M, et al. Donor natural killer cell allorecognition of missing self in haploidentical hematopoietic transplantation for acute myeloid leukemia: challenging its predictive value. Blood. 2007;110:433-440. (Pubitemid 47026866)
49. Leung W, Handgretinger R, Iyengar R, Turner V, Holladay M, Hale G. Inhibitory KIR-HLA receptor-ligand mismatch in autologous haematopoietic stem cell transplantation for solid tumour and lymphoma. Br J Cancer. 2007;97:539-542. (Pubitemid 47258461)